Gene Editing Market Size, Share, and Growth Forecast, 2026 – 2033

The global gene editing market size is likely to be valued at US$11.0 billion in 2026 and is expected to reach US$30.5 billion by 2033, growing at a CAGR of 15.6% during the forecast period from 2026 to 2033, driven by rapid technological advancements, expanding therapeutic applications, and increasing integration across research and commercial domains. As of 2025, more than 250 gene-editing clinical trials are underway worldwide, with over 150 currently active, underscoring the transition of gene editing from experimental research to clinical-stage applications.

The technology is also gaining momentum in animal and plant genetic engineering, enhancing disease resistance, productivity, and agricultural sustainability. These advancements are accelerating development across therapeutics, agriculture, and industrial biotechnology, while improving efficiency in preclinical and translational research. From a broader healthcare perspective, the World Health Organization highlights the rising burden of genetic diseases, with millions of newborns affected annually, driving sustained demand for precision therapies and advanced genomic solutions.